Latest Advisory

  • FDA Advisory No. 2016-144-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” na gawa ng The ACME Laboratories Ltd. – Dhaka, Bangladesh

    FDA Advisory No. 2016-144-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” na gawa ng The ACME Laboratories Ltd. – Dhaka, Bangladesh

    Read more

  • FDA Advisory No. 2016-144 || Public Health Warning Against the Use of the Unregistered Drug Product “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” manufactured by The ACME Laboratories Ltd. – Dhaka, Bangladesh

    FDA Advisory No. 2016-144 || Public Health Warning Against the Use of the Unregistered Drug Product “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” manufactured by The ACME Laboratories Ltd. – Dhaka, Bangladesh

    Read more

  • FDA Advisory No. 2016-143-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Puritan’s Pride Premium Folic Acid 400 mcg Tablet”

    FDA Advisory No. 2016-143-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Puritan’s Pride Premium Folic Acid 400 mcg Tablet”

    Read more

  • FDA Advisory No. 2016-143 || Public Health Warning Against the Use of the Unregistered Drug Product “Puritan’s Pride Premium Folic Acid 400 mcg Tablet”

    FDA Advisory No. 2016-143 || Public Health Warning Against the Use of the Unregistered Drug Product “Puritan’s Pride Premium Folic Acid 400 mcg Tablet”

    Read more

  • FDA Advisory No. 2016-142-A || Babala sa Publiko Tungkol sa Paggamit ng mga Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-142-A || Babala sa Publiko Tungkol sa Paggamit ng mga Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-142 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2016-142 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    Read more

  • FDA Advisory No. 2016-141-A || Babala sa Publiko tungkol sa Paggamit ng mga Pekeng Gamot na:

    FDA Advisory No. 2016-141-A || Babala sa Publiko tungkol sa Paggamit ng mga Pekeng Gamot na:

    Read more

  • FDA Advisory No. 2016-141 || Public Health Warning Against the Use of the Following Counterfeit Drug Product:

    FDA Advisory No. 2016-141 || Public Health Warning Against the Use of the Following Counterfeit Drug Product:

    Read more

  • FDA Advisory No. 2016-140-A || Babala sa Publiko Tungkol sa Paggamit ng Pekeng Albumin (Human) U.S.P. Human Albumin Grifols 25% Solution “Manufactured by Instituto Grifols, S.A., Barcelona, Spain”

    FDA Advisory No. 2016-140-A || Babala sa Publiko Tungkol sa Paggamit ng Pekeng Albumin (Human) U.S.P. Human Albumin Grifols 25% Solution “Manufactured by Instituto Grifols, S.A., Barcelona, Spain”

    Read more

  • FDA Advisory No. 2016-140 || Public Health Warning Against the Use of the Counterfeit Albumin (Human) U.S.P. Human Albumin Grifols 25% Solution “Manufactured by Instituto Grifols, S.A., Barcelona, Spain”

    FDA Advisory No. 2016-140 || Public Health Warning Against the Use of the Counterfeit Albumin (Human) U.S.P. Human Albumin Grifols 25% Solution “Manufactured by Instituto Grifols, S.A., Barcelona, Spain”

    Read more

  • FDA Advisory No. 2016-133-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-133-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-133 || Public Health Warning Against the Use of the Following Unregistered Drug Product:

    FDA Advisory No. 2016-133 || Public Health Warning Against the Use of the Following Unregistered Drug Product:

    Read more

  • FDA Advisory No. 2016-139-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Curing Pill”

    FDA Advisory No. 2016-139-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Curing Pill”

    Read more

  • FDA Advisory No. 2016-139 || Public Health Warning Against the Use of the Unregistered Drug Product “Curing Pill”

    FDA Advisory No. 2016-139 || Public Health Warning Against the Use of the Unregistered Drug Product “Curing Pill”

    Read more

  • FDA Advisory No. 2016-138-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Double J Go Shi Ashitaba + Guyabano (Angelica Keskei + Soursop) Liniment”

    FDA Advisory No. 2016-138-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Double J Go Shi Ashitaba + Guyabano (Angelica Keskei + Soursop) Liniment”

    Read more

  • FDA Advisory No. 2016-138 || Public Health Warning Against the Use of the Unregistered Drug Product “Double J Go Shi Ashitaba + Guyabano (Angelica Keskei + Soursop) Liniment”

    FDA Advisory No. 2016-138 || Public Health Warning Against the Use of the Unregistered Drug Product “Double J Go Shi Ashitaba + Guyabano (Angelica Keskei + Soursop) Liniment”

    Read more

  • FDA Advisory No. 2016-137-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-137-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-137 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2016-137 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    Read more

  • FDA Advisory No. 2016-136-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Jinling Bao Ji Pill”

    FDA Advisory No. 2016-136-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Jinling Bao Ji Pill”

    Read more

  • FDA Advisory No. 2016-136 || Public Health Warning Against the Use of the Unregistered Drug Product “Jinling Bao Ji Pill”

    FDA Advisory No. 2016-136 || Public Health Warning Against the Use of the Unregistered Drug Product “Jinling Bao Ji Pill”

    Read more

Additional Requirements on Applying Export / Commodity Clearance

In order the better facilitate the processing of your application for Export/Commodity Clearance the FDA-CSL would like to inform you the additional requirements need to be submitted:

Flash Drive or Pen Drive (USB) containing duly accomplished forms which are downloadable from the FDA Website under Common Services Laboratory (http://www.fda.gov.ph/industry-corner/downloadables):

  1. Export/Commodity Clearance Database
  2. Draft Export/Commodity Clearance Certificate

The Above requirements to be included in the receiving for Export/Commodity Clearance application shall enable our staff to prepare the certificate within our committed time (as reflected in the attached process flow) instead of having individually consumes bulk of our man-hour.

This shall effect immediately upon posting in the FDA Website.

For your information and guidance

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter